<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[ALK-Abelló &#x27; Bavarian &#x27; Genmab &#x27; Lundbeck &#x27; Zealand Pharma]]></title><description><![CDATA[<p dir="auto">ALK-Abelló ' Bavarian Nordic ' Genmab ' Lundbeck ' Zealand Pharma ' Hansa Biopharma</p>
<p dir="auto">Der er fest på <a href="http://Proinvestor.com" rel="nofollow ugc">Proinvestor.com</a> - for næsten alle de mest populære pharma- og biotekselskaber på sitet er steget i kurs.</p>
<p dir="auto">Helge Larsen gennemgår det sidste nye om virksomhederne inden for pharma og biotek ud fra den kvalificerede debat og chat på.</p>
<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/TsW-yRIVRmU" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/445076/alk-abell-bavarian-genmab-lundbeck-zealand-pharma</link><generator>RSS for Node</generator><lastBuildDate>Thu, 25 Jun 2026 04:34:51 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/445076.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 11 May 2023 11:22:06 GMT</pubDate><ttl>60</ttl></channel></rss>